Tap a claim on the ring to put it at the centre.
← We have neither the data nor the insight to use machine learning to…
8 connected korrents · 7 moments on record from 25 May 2023 to 10 Aug 2026.
Everything filed under design
design Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Read this korrent: We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic more often. We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic more often. Last stated 3 years ago
25 May 2023
DL
Derek Lowe — holds since 2023-05-25 — tap for who they are
Same subject: A compound's AI origin story is not by itself a reason to expect it to do better in the clinic. — tap to centre the map on it A compound's AI origin story is not by itself a reason to expect it to do better in the clinic. Last stated 2 years ago
13 May 2024
DL
Derek Lowe — holds since 2024-05-13 — tap for who they are
Same subject: No AI system today reduces either of the two risks that sink most drugs in the clinic: picking the wrong target, and human toxicity. — tap to centre the map on it No AI system today reduces either of the two risks that sink most drugs in the clinic: picking the wrong target, and… Last stated 3 years ago
25 May 2023
DL
Derek Lowe — holds since 2023-05-25 — tap for who they are
Same subject: Better drug candidates do not shorten clinical trials, because a trial's duration is set by operational and regulatory friction rather than by how good the drug is. — tap to centre the map on it Better drug candidates do not shorten clinical trials, because a trial's duration is set by operational and… Last stated 6 months ago
28 Feb 2026
RT
Ruxandra Teslo — holds since 2026-02-28 — tap for who they are
Same subject: Deep learning is not yet ready for the task that would actually add value in drug development: predicting safety and efficacy in humans. — tap to centre the map on it Deep learning is not yet ready for the task that would actually add value in drug development: predicting safety… Last stated 3 years ago
23 Dec 2023
AT
Alex Telford — holds since 2023-12-23 — tap for who they are
Same subject: AI's bottleneck was never its algorithms but how little data they were fed, which is why the field needed ImageNet rather than another model. — tap to centre the map on it AI's bottleneck was never its algorithms but how little data they were fed, which is why the field needed ImageNet… Last stated 4 weeks ago
10 Aug 2026
FL
Fei-Fei Li — holds since 2026-08-10 — tap for who they are
Same subject: There are few clear-cut cases in biopharma today where buying an AI system is obviously worth it. — tap to centre the map on it There are few clear-cut cases in biopharma today where buying an AI system is obviously worth it. Last stated 2 years ago
14 Oct 2024
DL
Derek Lowe — holds since 2024-10-14 — tap for who they are
Same subject: The human data an AI model would need to predict trial outcomes can only come from trials in people, so the loop runs no faster than the trials themselves. — tap to centre the map on it The human data an AI model would need to predict trial outcomes can only come from trials in people, so the loop… Last stated 6 months ago
28 Feb 2026
RT
Ruxandra Teslo — holds since 2026-02-28 — tap for who they are
Same subject: Not every bottleneck on medical progress is one AI can remove, and which ones will remain can be guessed at now. — tap to centre the map on it Not every bottleneck on medical progress is one AI can remove, and which ones will remain can be guessed at now. Last stated a year ago
2 Aug 2025
JT
Jacob Trefethen — holds since 2025-08-02 — tap for who they are